Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) Gross Profit (2018 - 2025)

Historic Gross Profit for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $113.0 million.

  • 10x Genomics' Gross Profit rose 188.36% to $113.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $443.9 million, marking a year-over-year increase of 709.29%. This contributed to the annual value of $443.9 million for FY2025, which is 709.29% up from last year.
  • 10x Genomics' Gross Profit amounted to $113.0 million in Q4 2025, which was up 188.36% from $100.3 million recorded in Q3 2025.
  • 10x Genomics' 5-year Gross Profit high stood at $125.1 million for Q2 2025, and its period low was $86.9 million during Q2 2022.
  • Its 5-year average for Gross Profit is $104.0 million, with a median of $102.5 million in 2021.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 23764.65% in 2021, then crashed by 2165.57% in 2022.
  • Over the past 5 years, 10x Genomics' Gross Profit (Quarter) stood at $115.9 million in 2021, then increased by 3.0% to $119.4 million in 2022, then fell by 3.03% to $115.8 million in 2023, then dropped by 4.17% to $111.0 million in 2024, then grew by 1.88% to $113.0 million in 2025.
  • Its last three reported values are $113.0 million in Q4 2025, $100.3 million for Q3 2025, and $125.1 million during Q2 2025.